Intelligent RIM for Medical Device Manufacturers: RegDesk

RegDesk is an intelligent Regulatory Information Management (RIM) platform purpose-built for medical device manufacturers to streamline global compliance, automate submissions, and stay ahead of evolving regulations. By combining live regulatory intelligence, AI-powered workflows, and end-to-end tracking in a single platform, RegDesk helps regulatory teams reduce risk, accelerate approvals, and operate with greater efficiency and confidence.

In this episode, we speak with Priya Bhutani, founder and CEO of RegDesk, an AI-powered regulatory information management platform for the medical device industry. We discuss the complexities of global regulatory compliance, the challenges faced by regulatory teams, and how RegDesk’s platform leverages AI to streamline the process. Priya shares insights into the importance of integrating technology in regulatory affairs and the future role of AI in transforming these processes. The conversation highlights the shift towards more strategic roles for regulatory teams and the necessity of adopting AI to stay competitive.

Follow SourceForge:

SourceForge.net - https://sourceforge.net
SourceForge LinkedIn
SourceForge X (Twitter)
SourceForge Facebook

Interested in appearing on the SourceForge Podcast? Contact us here.

The SourceForge Podcast is the world's largest B2B software podcast.

Transcript

SPEAKER_00 0:05

Hello, everyone, and welcome to the SourceForge podcast. I'm your host, Bo Hamilton, and today I'm joined by Priya Butani, founder and CEO of Rigdesk, an AI-powered regulatory information management platform built specifically for the medical device industry. Now, while we think about the technology behind medical devices, I think it's fair to say that we tend to think about the devices themselves. But there's a whole other side of the industry that most people never see, and that's the software and the actual systems that get those devices approved and into the hands of the doctors and the patients who need them and rely on them. And getting a medical device approved in one country is hard enough. Now imagine doing it across 120 different countries, each with their own regulations. They have their own timelines, uh, they require their own paperwork. And I think for a lot of regulatory teams, that process still uses many antiquated solutions like spreadsheets and emails and just a whole bunch of manual work and effort. And when regulations change, which they do all the time, it just means scrambling to update submissions that took months to put together in the first place. So it can be a real headache and a real challenge. And my guest today saw that problem firsthand and decided to build a better way to handle all of this. So I'm just really excited to hear about what Priya's company is doing in the space and just to dig into what makes global regulatory compliance so complex in the first place. So without further ado, Priya, welcome to the podcast. Glad you can join us.

SPEAKER_01 1:33

Thank you, Bo. Thank you to SourceForge for this opportunity. Glad to be here.

SPEAKER_00 1:38

Yeah, I'm excited to dig into this some more. So I think before we really get into Rigdesk itself, I do want to start with your background because I think it really helps set the stage. You started your career as an engineer at Baxter. You moved into regulatory consulting, and then you launched Rigdesk back in in 2014. Um and I that's really the uh SparkNotes version of it. Um what was the the moment you realized this company and your solution needed to exist?

SPEAKER_01 2:08

Yeah. Well, a fun point about a note about Red Desk is that we actually started the company at a Google hackathon, those weekend hackathons. That's where it was actually incepted. But I had this idea prior to participating in the hackathon. We saw the the whole idea of hackathon is you build your minimal viable product and you prove that this that there's potential if anyone were to invest further into this idea. And we just over the weekend of sharing the thought and the idea behind Red Desk, we actually received a lot of feedback from actual companies and regulatory folks asking for signing up for whenever the platform would be ready. So it became, it sort of validated the idea. But the impetus really came from the drive from when I was uh when I transitioned over into regulatory affairs, I recognized that companies of all sizes, it didn't matter how big you were and how many resources you had around the world, they all struggle with the same thing, which was global expansion. And another shortcoming was that they all rely on distributors or consultants. I mean, there was just no technology, there's just no other way to go about expanding your products to international markets. It's quite limiting. And that really was the reason for starting Red Desk. Our mission from the very beginning has been to modernize regulatory affairs, to introduce technology into the process. And that's that that's how we got started.

SPEAKER_00 3:59

Interesting. That's interesting to hear that you've you started from that hackathon, um, which we've covered a lot of the um hackathon-related um kind of bug bounty programs over on um our sister site slash dot. So I'm pretty familiar with that. And it's interesting to hear that your company was kind of bored from that effort. That was back in 2014 era.

SPEAKER_01 4:20

Yes, and there was this hackathon was specific to health care ideas. It wasn't generic, though it was perfect. Philadelphia has a pretty solid healthcare seat and health tech and a lot of hospital systems. And this Google hackathon was specific to that, which was quite relevant. That's why I participated in that.

SPEAKER_00 4:43

Okay, very cool. And then I also have in my notes here since then, you've you've been recognized as one of Inc. top 100 female founders, which I think is really impressive. So kudos to that accomplishment. And then uh Rig Desk has been named Gardner Representative Vendor for both regulatory information management and regulatory intelligence. I also want to get that out there. So you guys are doing some really um valuable, important work. So just want to tell the listeners kind of how how much value you guys are are offering in this space. Um and I I bring up the origin story to set the stage. You know, a lot has changed since 2014. I mean, 12 years later, um, we're we're looking at all these automations, which of course I want to ask you about AI and how that's playing into the to what you guys are doing. Um, but uh before we get into that, for our listeners who might not be super familiar with this industry and maybe they've heard the term, you know, regulatory information management, but aren't sure what that really means, um, how would you just describe, describe that term, describe what Rigdesk does?

SPEAKER_01 5:44

Yes. To a layman who has no familiarity with this space, we will for a moment shelf this term frame or regulatory information management system to give some background. If you have a medical product, and medical product has a definition that is defined and created by health agencies, every country has its own health authority. For instance, and in the US, we have the FDA. The FDA's task, just like we are familiar with FDA dealing with medicine and getting drugs approved. Similarly, they also approve medical products, medical devices that you see at doctors' offices, hospital systems, anything that's diagnosing you, that's in any medical equipment that you see. Everything is defined that classified as a medical device. These medical devices cannot be exported in countries around the world just because you have FD approval. Every health agency requires that you submit so-called an application to them where you explain and describe what product you're trying to introduce into that market, why it's beneficial, what is unique about that product. You provide, you have to also convince the health agencies in all the countries around the world where you want to sell your product that your product is safe and effective. Ultimately, that's a goal, that the product is safe and effective, and you have to provide evidence for it. So these applications are quite lengthy. This is not a swarm that you fill out and then ship your product. And the process is expensive, it costs thousands of dollars, and it's lengthy. It can take several months to sometimes even two, three years to get your one single product approved in a particular country. Whereas in medical device manufacturer, you're typically thinking global, you are usually selling in more than one country, and it gets to be quite complicated because rules and regulations are constantly changing and there are new legislations. It's an evolving landscape, to say at least. And you then your products expire. There's a lot of compliance and the maintenance of the products that you approve on the market, and it's quite a complex process, and it's also very technical because you're dealing with the rules and regulations and dealing with health agencies. Most of the companies had been using spreadsheets to manage this process. As I mentioned earlier, consultants, a lot of old traditional, fragmented ways to manage and get these products approved, their products approved in global markets. And this concept of RAM is a regulatory information management system. The idea is to introduce technology, a software solution that allows companies to manage their processes. So what's unique about our platform is the technology aspect, which we'll dive into a little later. But what our platform allows a medical device company to do is one, understand and keep apprised of all the regulations that are changing around the world. Then they can do regulatory strategy planning as to where they should bring, introduce what product, where it's fastest, where it would take them more time. They can do all that planning. Then they can what we call the build phase. So they can actually build these applications, leveraging AI through our platform, track these registrations around the globe that maybe know where each SKU has been approved, to then make the maintenance bit, which is once your product's out in the market. And if you make any change to that product, let's see cheap the design or label changes, then you have to reassess what would be the regulatory impact if you were to make that change. And that process is also all managed through our platform. So we're an end-to-end solution that essentially digitizes regulatory operations.

SPEAKER_00 9:57

So I imagine when you're you're you're working with uh companies, um, the companies you're working with weren't necessarily using maybe purpose-built software before they they found you and discovered what Rigdesk offers. Um I mean, from what I've seen, a lot of the regulatory teams, even at larger companies, they're still managing this stuff, like you were saying, with with spreadsheets, with email chains, maybe there's like shared folders. Um, and then the teams themselves can be relatively small. So that kind of adds to the you know, the burden of everything. And when you have a system that doesn't work as efficiently as it should. Um maybe you can elaborate on where the those approaches start to really fall apart.

SPEAKER_01 10:39

If you have a medical device company and you have, let's say, thousand product SQUs, you're not typically selling every SQU in every country. You have certain SQUs that are specific to Japan and that's certain ones to China and then Latin America. And you're doing that all through a spreadsheet, an Excel sheet that someone can go and change the formula on, or somebody put the on vacation and forget to update. The the one of the big challenges and the risk, it's not even a challenge, it's actually a risk to an organization is that once your product is approved, you're selling that product. If now that product is to be renewed in five years and that license expires because you were tracking it to a spreadsheet, then you have to take that product off the market and start the renewal process again. Or actually, not even renewal, registration again, which means now the profit and the income that you were generating from that product on the market, you're no longer doing so because the product has to be removed from the market. That's that's a huge risk to an organization because the product has to be remote. It can slow everything down. It it it's it's a PL impact, is what it is. That's one. Another is, for example, if you're not up to date on what's changing around the world, because different legislators sometimes not even alerting you, you could subscribe to their newsletter and still not be aware that something changed, that there's a new regulation or new guidance that you should be following and be complying to. Then when health authorities come and audit you, the first thing they ask is, are you keeping up to date to changes to regulations? And if you're not, that that in itself is a non-compliance, you know, they'll that's a stamp of non-compliance. Now you have to address that issue and you have to have processes in place now. So there are a lot of companies go through audits and there's just a lot of compliance risk for doing it this haphazardly in a way. And then this actually leads to companies constantly reacting as well because they don't have the right tools in place and everything is manual. You have regulatory peak folks who should be doing strategic work, doing a lot of it in this creative work. Also, there tends to be a lot of redundancy of effort as well, where, for example, you have to submit these 10 documents to the health agency in Nigeria, and now the Saudi government's asking for the same 10 documents. So you're constantly repeating the same amount of work rather than working in a smarter way, leveraging AI. I mean, now the technology is so smart that it can do a lot of this administrative work for you. So there are just a lot of risks. The companies expose themselves to just way too much risk, missing deadlines, missing renewals, not be compliant.

SPEAKER_00 13:41

Yeah, that that makes sense. I mean, it's uh to your point about the reactivity, and uh, I think a lot of people outside of the regulatory industry might not uh appreciate maybe just how uh reactive uh the work is. I mean, you got the you got the FDA making changes um on one side of the equation, you got the EUs rolling out their own requirements on the other, you have dozens of other countries have all their all their various compliances uh on top of that. Um, so it really creates this this burden and this back and forth um and constant sort of uh stop and start, and um you're you're constantly having to like go back and and dot your I's, cross your T's, um, that sort of thing. And I think also just the uh the scale and how how much of a global challenge this is. You know, you're not tracking regulations in five or ten countries. Again, it's 120 plus countries, um, each with their own authority. So it's it gets pretty complex and it's a it's a definitely a big challenge you guys have set out to to try and solve. But um, how do you actually stay on top of all that uh from a solution standpoint? Is that more of like a tech problem? Is it a people problem? Um does it lead into this uh, you know, kind of the AI solutions you've devised? Um where's kind of the where does the problem lie?

SPEAKER_01 14:58

Yeah, the problem is in the process and the lack of tools that companies use to stay on top of regulatory changes. Most companies don't even have a regulatory intelligence team, their regulatory team in general doing all the work and then has the onus to keep on top of changes, which means they are subscribing to newsletters. Now, some bigger companies will have a Reg Intel team, but they also many times lack tools. What they do is they'll subscribe to newsletters and they attend conferences, et cetera, and they're hoping to gain information that way. And then what they do is they'll aggregate all this information, they'll say, okay, there's a change in China, Japan, wherever. Then they create a newsletter over the course of a month that they disseminate across different business units, especially for a large company. Then it's the responsibility of each business unit to read that newsletter and determine what's relevant to them. On top of this, the actual expectation of a health authority when an auditor comes in is not just, hey, do you are you keeping up to date with changes? But what they're asking is, great, you are keeping up to date with changes to regulations internationally. But then have you performed an assessment to understand which products in your product portfolio will be impacted by that change? And then have you performed further assessment to determine what that impact is? Does that mean you have to now re-register? How does this change impact your products? First, if you are already delayed, but the change is taking place daily and you have to wait for an entire month to receive the newsletter, that too is very generic and high level, and you have to dig deeper. That's a lot of manual work and you're already behind. We encourage companies to find tools because now, especially with AI, we established regulatory intelligence very early on and we built our rim platform on top of it. That's one of our big advantages. Most resolutions don't have integrated regulatory intelligence, but we find that to be one of the key vital, I would say, modules or capabilities over our rim should be reg intel. How do you make any regulatory decisions without having the reg intel? You need the intel first. We encourage companies to have tools because now what AI can do is one, for even a system like ours, we alert our clients every single day. We let them know what's changed around the world because it gives them enough, sufficient time to then act on that change. And then we have workflows that allow them to not only get alerted on the change in receipt notifications, but actually perform the impact assessments that the agencies are asking for. That way, when an agency comes, they can show here are the changes, these are the products that are being impacted in these markets, this is the impact, and this is our action. I call to action for this. That's the loop, the compliance loop that you have to complete. And that's what our system does. So, yes, I mean you can only imagine the risk of doing it manually, subscribing to newsletters versus letting AI, especially with the genetic AI tools, because it can also provide Q-rated intel that can disseminate information. So we can say, okay, this business you're focused on robotics, and this business you're focused on, and our delivery devices. So now you you require different intel. And so you get Q-rated reports leveraging technology and AI.

SPEAKER_00 18:56

Okay, so let's talk about that that intelligence layer and then and then get into some of those AI features. Because you've got you got this intelligence layer, and you have this expert network of some 4,000 regulatory experts around the world, which um we can we can unpack some more too. But um, I want to talk about the platform. I know a lot of like the traditional uh you know uh regulatory information management platforms, they're they they've become these tracking tools. So you upload your documents, you log into your, you log your submissions, um, and that's really the main functionality, I would say, right? But then from what I understand, Rigedesk goes much further and actually guides teams through that process, integrates with other systems, and kind of starts to really work and control all the different uh mechanisms at play to get a to help a company get a finer understanding and really work through the problem and find a efficient solution. Um maybe you could talk about like how how Regdes fits into that workflow that teams typically um handle. And then what is what does Regdes do differently than some of the other platforms out there? Like what's your main value proposition?

SPEAKER_01 20:06

Yes. So our main volume value proposition, I would say the top three is one, the technology infrastructure. We are using the latest technology we always have, and we're constantly keeping up to date on the technological development and the back-end infrastructure. Because of that, the second point is we have the most amount of workflows embedded within the system. The older technology platforms are limiting, they don't allow you to build workflows on top of workflows. They had too many limitations, and that's one of the problems. And then it also, the older the technology, the worst user interface and experience that you have, that also impacts the value clients get out of your platform. And then the the th the third is the Reg Intel. That's a unique point to us to have integrated Reg Intel because our system is built on top of Reg Intel. So, for example, before you even take action to decide to submit a product in Saudi Arabia, for example, most companies would not know what exactly or what are the most current requirements in that country, right? That's the first thing anyone would be to find out. What do I need to do? How do I do it? And our system gives them that formula of exactly what's required, when it's required. Here's the legislations and here are the guidances that support this. If we give you everything that you need, and then that Intel actually converts into workflows because now that you have the Intel, now let's get to action and start collaborating, whether that's with your internal team or whether that's with your distributors, external business partners to put together those submissions. Another point I want to make is that because we use the latest technology, we have been a pioneer in the regulatory space to introduce. Our systems, system now is AI native platform where we're using agentic AI to help companies work in a smarter way. So it's what we tell our clients or any prospects who come to us is that if you're looking for a platform that is going to truly modernize your regulatory processes and that's your vision, then we are the platform. We are the best solution for you, especially if you're a mid to large enterprise company. That is what we do best. If a company is looking for the cheapest platform and it technology really doesn't matter to them, they just want to go one little step above a spreadsheet, then yeah, there are lots of solutions out there. We can also support, but the the best alignment is companies and leaders think, you know, I eat my teeth, leveraging AI, how do they work smarter? Can they build submissions faster? They've been manning these things, then that's where we are a leader.

SPEAKER_00 23:01

Okay. So if you want the bleeding edge, you know, technology and you want to kind of be forward-facing, it's safe to say that you guys are the leading provider in that front. Um and it's it's interesting to hear about some of these AI features in this industry because it doesn't, I mean, I know that with regulatory and the medical space, you have to deal with a lot of uh regulations, obviously, but um a lot of privacy components. Um one security breach can really decimate a company. It's just like there's more um it it seems like it's inherently a little bit further removed from some of these newest, uh, from the newest technology um than other tech-facing uh tech industries. Um so I want to I want to unpack that some more. I know that regdesk um can actually take data from a previous submission, let's say, and use it to sort of auto-populate forms for new markets. That's like one use case, um, so you don't have to like go in there manually and and um every time a team files in a new country. Um and then just like those little little automations can really uh accumulate and start saving some real time, right? Like the what's the typical like process timeline for um a submission? Is it like a matter of months in some cases, is it weeks?

SPEAKER_01 24:20

So a submission preparation. So there we call them four pillars: the plan, build, track, and maintain. If we just focus on the building part, you're you're building submission. Submission preparation is also an arduous process. One, you need to understand what the requirements are for that market. Then you need to put together this application, right? You need to and have your sterilization report, your validation report. There's a lot of evidence that you have to provide for that, for that product. And it is quite redundant. So, what are one of the ways, and this is actually one of the biggest ROIs because it can take companies, or at least our clients have reported savings of 35 plus hours per application that they generate, which is massive. It can take several weeks, it can take a lot of hours to build these applications. And our system saves them time. And so once once we have the base application and we have we have enough, we don't even need the base application. If we have enough data in our system to learn about your product and we have documentation, then our system can leverage that data to auto-copulate your sufficients for you. So imagine that let's say you did an EU European submission or you submitted an application for the FDA and now you want to go to India. Instead of now having to repeat that work all over again, which is what companies do, instead of that, you'll just simply select India in our system and our AI will auto-populate as much of the application as it can for India. So within seconds, you can have 60 to 80% of your application auto-populated. That's huge administratively, because most companies, especially if you look at mid to large, their goal per year is typically 100 to several hundred applications that they have to submit. And this accumulates, right? This compounds the savings.

SPEAKER_00 26:20

So do you find that when you have when you work with a team to integrate some of these um tools, these AI tools, um do they, does the role of the team shift into kind of becoming a more judgment-based and like their goal is is less like punching in numbers and doing some of the redundant tasks to kind of reviewing what some of the agentic AI has has delivered for them? They be they can become like like the they have to kind of review and check. Um, and then if they have any time savings, which it sounds like they're you know able to save on average 35 hours per submission, um, are they able to reinvest that time into other areas that are more uh you know productive or um rewarding, let's say? How is how is that causing the shift?

SPEAKER_01 27:10

Yes, because they're able to do more work, they're able to meet those deadlines, complete more work, have more strategic conversations. When you let's say you have a sufficient and I'll give Saudi Riga, for example, another, and without the tool, you would have to reach out to the agent at Saudi and say, hey, what do you need from me? And then you wait, because now to wait for them to tell you what they require, what documents they need. Once they send to your documents, you have no way of verifying, right? You have to go first buying the law on the Saudi health website. Then if it's in Arabic, you have to now translate that law, read it to decipher whether the requirements provided by your local regional partner is exactly what they require, something's missing. No one has time to do all that work. So you receive the requirements if it's holiday day or if it's a weekend there, yeah, you just so much time gets wasted. Whereas with our platform, it's within seconds you create workflows and you're communicating. So because they also have the rake intel, they no longer ask the distributor what is required. They are proactive. They proactively tell the distributor, this is what we think you need. Tell us, just add on to this list if you need anything additional, right? They're they're just so much more efficient and getting work done versus being flung by and delays and the latency involved with all the bureaucracy and the holidays and the outreach that they have to do. Their work, they are not hired to constantly follow up with the distributor because the distributor hasn't responded to them in three weeks. Or when the distributor comes back two months later complaining that so and so is missing from the from the documents and now they have to search. Like it's all this busy work instead of this administrative work. They are having strategic conversations and they're doing the reviews and and getting these submissions. Regulatory is the last step to a company making money off that product. It's the last hurdle. Without getting regulatory approval, you could have the most innovative product. It means nothing. No company can ever generate any revenue from it because it's not on the market. So it's a critical role. And the faster, if you can enable with through proper technology, enable regulatory teams to work faster, get these submissions done faster, learn from these submissions using agentic AI so that those same mistakes are not being made and they're continuously improving the process. That's another area where AI is being generated. It's it's well worth the investment for any organization to have such a tool.

SPEAKER_00 30:02

Maybe you could also talk to uh speak to the um what you're doing to ensure accuracy and and the trust in the technology, right? Because I mean when you're when you're dealing with governments from all around the world, you're in this last, there's a lot of pressure from companies to uh, you know, get their medical devices approved and be regulatory compliance. Um so and then you know it's it's uh it's an important decision. Um you want to make sure all the uh the right facts and information are being you know translated over and and communicated. Um so how do you solve that trust issue? Like, do you notice teams um like apprehensive at all about incorporating any of the tools? Um, do you have a good kind of robust system to make sure everything is on track and and accurate?

SPEAKER_01 30:51

It it's a good question because I'll answer it in two separate parts. So, one, let me address how dubious some folks are in certain teens and organizations about using AI. I would say if we were having this conversation last year, I would say, yeah, they are just not ready for AI yet. Even though every conference is talking about AI and they hear about AI, they understand AI is ubiquitous, but they're just still not ready. There has truly been a shift. I was telling this to my team that just in the past week of probably conversations with some prospective clients, when you ask them what do you want to discuss, they don't say AI, but when the leader gets on the phone, every question that they're asking is AI related. Can AI, do you have AI that can do XYZ? And can it do this and can it do that? So subconsciously, they are ready for it. And I think they're trusting AI more. In fact, health agencies are using AI. So a lot of leaders are recognizing that if they're not using AI, because AI is everywhere, not just in regulatory, that if they're not leveraging it, they will really fall behind. And many, most companies are using AI in their day-to-day. They have approved AI platforms that they're allowed to use. Even, I mean, grandparents using AI now. So it's becoming a very common theme. It's it's helping. So they're the trust factor, it's increased a bit more just because of their workforce and in the personal life. There's a lot of encouragement to use AI and they see positive results. Now, the way we validate that and our AI is trustworthy. Well, one, we don't believe in the entire platform be just AI driven. It's heavily AI driven. However, with every step, there's human in the loop. So we do, they get to review the requirements if there are any changes that need to be made. It's all editable. It's not that the system automatically generates a submission and submits it to the health authority. They get to review it, they get to approve it, they get to modify it, all of that. So there's the human in the loop that that's very important to us, and that's there. Second, the way our AI works is it's not a largely that we aggregate all of our kind data from every company and then learn from it. It's actually quite specific to each company's products and their documents. Because when you're building the submission for Company X, you need to learn the information about Company X's products, company Y's products and their documents would be learning from that would be irrelevant to them because their test reports, everything's unique to them. So our models also based on that, where the AI provides a tell based on their products, their documentation. That in combination with the the human in the loop and and also our Reagan tell, though we leverage AI, there is a human factor, it's human curated. So that eases a lot of the stress and anxiety around using the AI on our platform.

SPEAKER_00 34:12

Yeah, absolutely. I mean, there's a few things that stood out there, is just it's fascinating to think about the societal effects of AI and like you were saying, how much it's changed just in the last year amongst, you know, the conversations we're having with uh friends, family, and and those in the industry. I mean, we obviously here on the Source Forge podcast, we talk AI is like the center point. We always it's always it always comes up and it's always a main kind of pillar of a question of how companies are integrating it. Um and a lot of the the trust really seems to be from the consumer level with some of the AI chatbots. But when you look at like the um the integrations companies are doing behind the scenes with some of the services they offer in the SaaS space, it's um there's some real utility and there's a lot less reason to be skeptical, let's say. Um and then I think it's also important you mentioned having that human in the loop to review everything. That is like always really good to reassure, and and and you never want to ship something that's unchecked, let's say, by one of these automated tools, because they make they do make mistakes. I mean, people make mistakes, these machines make stick, they're getting they're getting better day by day. And then I was gonna ask you about like what advice you had for regulatory listeners if there was like one big takeaway. But it sounds like you mentioned you kind of have to start incorporating AI, and if you don't, you're gonna be left behind, right? Like, is that kind of the biggest takeaway you would say?

SPEAKER_01 35:34

So let me actually give you an example of so Gartner, uh, they the the analyst there, they every couple years they release their analysis on the brain space, and they have been analyzing the brain space for quite a few years, especially on the pharma side, because pharma is always more tech that I guess smart, and they are more open and willing have willingness to adopt technology, and they have. So this whole rape concept came from pharma world, and what Garpner analysts have summarized and sort of concluded from this is that they said that one technologies, if if any organization wants scalability and ROI, you have to have technology platform tools in place. Number one. And then they show this graph that shows if you have these one-off tools that perform only one function, then you just don't have that scalability and your ROI is going to be small as well, right? But as you have an integrated tool, which they call a holistic rim, meaning what you mentioned earlier, that a tool that has a lot of the functionalities that regulatory teams need, and then it can integrate with their external systems, their document management and QMS and other systems, that becomes a holistic solution. And companies should strive for that because that's where you get the biggest ROI and scalability. I would first suggest for companies that still are not able to get budgets and their leadership does not understand the importance of having technology, you're already very, very behind. Forget AI, just gag technology platform. It's the way they're performing their functions using homegrown tools, they're just not scalable. Number one. And my second would be if you are now today's day and age searching for technology, it would be your such a big disadvantage for you not to opt and select a technology that is using AI. If Regdesk is also in the mind frame of not just, you know, whatever our legacy system is, just continue maintaining it and build on top of it and not worry about AI, we may not be in business in the next two years, honestly. So it's the same application that you just, if your competitors are working 10 times smarter than you and you're still chugging along using Spreadsheet, there are many big businesses in other industries that have closed doors, right? Overnight. So it's it's a massive business risk. And I don't know how a company could have an appetite for that level of risk. So yeah, I think that getting technology, having a bigger picture when you're selecting technology, I understand for some, they may need to start off small. There's no problem with it, but then have the bigger picture of a way that ultimately you want a holistic solution. So selecting the right platform that'll get you there, and then also selecting a tool that a platform or a company that is focused on AI technology.

SPEAKER_00 38:58

Yeah, well said. Absolutely great takeaways. I think that's very true. It's it's I can on one hand, I can see why maybe a company um they've been doing uh things for a certain way for for you know the last decade, let's say. Um it's it's hard to kind of motivate yourself or or get the team to switch gears entirely and adopt some of this new technology. But for the reasons you mentioned, I mean, you have to, you have to now is the time to adopt. Things are moving so fast, the competitive uh the landscape's getting way more competitive, um, and you're just gonna be left behind. And I think also a lot of this information, a lot of these tools are becoming more democratized too. So um, you know, they become, there's not only more solutions, it's just easier to adopt in a way. If you if you don't get so overwhelmed um and you maybe start small, the point is you have to start in some way, shape, or form to start to start moving and um getting with the times. Um but that's uh great, those are some great takeaways. I want to um kind of end on this note of of this forward-looking approach. Um, obviously uh the regulatory teams are moving, um, you know, they're they're switching gears to become almost like gatekeepers to being treated more like uh strategic partners within the organizations. There's all these the AI tools coming down the pipeline. Just looking ahead, how do you how do you see the role of regulatory teams changing over the next few years if we can even predict that far down in the timeline?

SPEAKER_01 40:28

It would be leveraging a gentic AI tool. It would be where language will no longer be a barrier. You would be able to speak and communicate with a gentic AI tools in any language, and they can perform function because AI is agnostic to languages. It can actually beat and then give you an output in English or the language of your choice, which is fantastic. So that in itself will bring global teams together and it just makes it easier to work using one singular platform. And yeah, I think the it's going to be more and more the agenda GI capabilities as those become stronger, which they are day by day, week by week. It's leveraging that in a and the right tech company will know how to use that, the latest technology and apply it to the applications that are necessary for regulatory teams. The future will be where regulatory teams can predict before even submitting their applications to the health agencies, what the probability would be of them, I guess, getting sort of digrading bit, you know, what's the probability of it succeeding on the first round, or predicting sort of what the health authorities might find as gaps, or uh determining or ascertaining the gaps in the submissions before they're even being submitted, the the predictions and understanding how are they doing a comparison to other companies, being able to, and as health agencies are also adopting these AI tools, they can also do revisions past or of submissions. And this this whole timeline of several months before an application gets approved, it could be strong. The AI can do that quick initial review before it gets even handed to the to the to the auditor reviewer who's reviewing it submission. So there's a lot of capability here. It'll medtech is slow to move, but I think they need to just take that first step. But the applications are there. And actually they're coming up as I was mentioning earlier when as I'm speaking to leaders nowadays, they have a plethora of applications that they want to leverage AI for, which is excellent because it gives you ideas as well.

SPEAKER_00 42:56

I love that. I think that's I think it's it's just a good reminder too. It's really all about getting medical devices and diagnostics into the hands of the doctors and the patients who need them, right? And so every month the device is stuck in that regulatory limbo is just another month that let's say a patient doesn't have access to potential uh a device that will really help them out. So um, you know, that's I think a great way to frame it. And um I I think it's really exciting to see what technology you're incorporating and um your mindset um with some of these fundamental, crazy new tools um that we have available to us. So before I let you go, is there um a link you'd like listeners to perhaps follow, maybe to get in touch with you and your team or learn more about what you guys are doing over at Rig Desk?

SPEAKER_01 43:44

Yes, absolutely. We send out monthly newsletters that are focused on alerts. We have blogs where we keep everyone alerted. We have our an excellent resource page as well if you're just needing to understand regulations in different countries. We try to provide a lot of free resources to our clients. You can go to our website. It is regdesk.co, not comp.co, and you can access everything there. And if you'd like to speak to somebody from our team, we'd be more than happy to speak to you. And you can just contact us at deskdesk at regdesk.co.

SPEAKER_00 44:20

Perfect. All right. That's Priya Butani, founder and CEO at Regdesk. Priya, thank you so much for everything you shared with us. I think this has really been a great conversation.

SPEAKER_01 44:31

Thank you, Bo. Thanks for the opportunity. Appreciate it.

SPEAKER_00 44:34

Absolutely. Thank you, listeners, for listening to the SourceForge podcast. I'm your host, Bo Hamilton. Make sure to subscribe to stay up to date with all of our upcoming B2B software related podcasts. I will talk to you in the next one.